期刊
TUMOR BIOLOGY
卷 31, 期 6, 页码 605-611出版社
SPRINGER
DOI: 10.1007/s13277-010-0076-y
关键词
Hepatocellular carcinoma; Nuclear factor-kappaB; Apoptosis; Gene therapy; Real-time PCR; Small interference RNA
类别
资金
- Chinese National Natural Science Foundation [30671081]
- Elitist Peak in Six Fields [2006-B-063]
- Medical Sciences of Health, Jiangsu Province, China
Nuclear factor-kappaB (NF-kappa B) is a transcription factor and antagonist of apoptosis during liver regeneration and closely related to the formation and development of hepatocellular carcinoma. In the present study, we investigated the effect of small interference RNA (siRNA)-mediated inhibition of NF-kappa B on growth of human hepatoma (HepG2) cells. Our data indicated that the expression of NF-kappa B/p65 mRNA was significantly higher in the HepG2 cells than that in the normal liver (LO2) cells before transfection, and the expression of NF-kappa B/p65 in the HepG2 cells with NF-kappa B/p65 siRNA (100 nMol/L) transfection at 72 h was reduced at the levels of mRNA (93%) and protein (62%) using real-time reverse transcription-polymerase chain reaction, enzyme-linked immunosorbent assay, and Western blotting. Interestingly, the apoptosis index of the HepG2 cells increased up to 85%, detected by Annexin V-fluorescein isothiocyanate, suggesting that NF-kappa B is overexpressed in hepatoma cells and can be inhibited by NF-kappa B/p65 siRNA through the apoptotic mechanism. Thus, we conclude that NF-kappa B is a potential molecular target for HCC gene therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据